Effect of Tofogliflozin on Systolic and Diastolic Cardiac Function in Type 2 Diabetic Patients.

Munemitsu OtagakiKoichiro MatsumuraHiromi KinKenichi FujiiHiroki ShibutaniHiroshi MatsumotoHiroki TakahashiHaengnam ParkYoshihiro YamamotoTetsuro SugiuraIchiro Shiojima

Published in: Cardiovascular drugs and therapy (2020)

In addition to conventional oral glucose-lowering drugs, additional tofogliflozin administration had a favorable effect on left ventricular systolic and diastolic function in patients with T2DM.

Keyphrases

left ventricular
hypertrophic cardiomyopathy
cardiac resynchronization therapy
heart failure
acute myocardial infarction
left atrial
mitral valve
aortic stenosis
blood pressure
blood glucose
metabolic syndrome
adipose tissue
atrial fibrillation
percutaneous coronary intervention